An article in NEJM Catalyst touts the value of multidisciplinary teams in cancer treatment. The group of authors conclude:
“The long-term cost of care needs to be further investigated, but the treatment changes based on multidisciplinary team recommendations likely led to improved outcomes or reduced cost, including lower downstream costs from complications or poor disease outcomes, based on studies in other institutions. True cost of treatment is difficult to quantify in a retrospective fashion in our study and would require further prospective study. Though the precise value of multidisciplinary team discussions may be difficult to quantify, multidisciplinary team discussions result in improved disease outcomes and better coordination of care, and may decrease cost of cancer treatment.”
To read the article, please hit this link.